YOFC (06869): Abnormal fluctuations in stock trading, no significant information that should be disclosed has been omitted.
Changfei Optical Fiber Cable (06869) announced that the closing price of the company's stock has increased by more than 20% over three consecutive trading days from August 4, 2026, to August 6, 2026. According to the relevant provisions of the "Trading Rules of the Shanghai Stock Exchange," this constitutes a case of abnormal stock trading fluctuation.
YOFC (06869) announced that the closing price of its stock has diverged significantly, with a cumulative increase exceeding 20% over three consecutive trading days from August 4, 2026, to August 6, 2026. According to relevant provisions of the "Shanghai Stock Exchange Trading Rules," this constitutes an abnormal fluctuation in stock trading.
In accordance with the relevant regulations of the Shanghai Stock Exchange, the company has verified the related issues and provides the following explanations:
(1) Business Operation Situation: Based on the companys self-inspection, its daily operations are currently normal, and there have been no significant changes in the industry environment.
(2) Major Events Situation: Based on the companys self-inspection and written confirmation from its largest shareholder, China Huaxin Post and Telecommunications Technology Co., Ltd.: As of the date of this announcement, neither the company nor its largest shareholder is aware of any major events that would affect the abnormal fluctuations in the companys stock trading, and there is no undisclosed significant information that should have been disclosed, including but not limited to major asset restructuring, issuance of shares, significant transactions, business reorganization, share buybacks, equity incentives, bankruptcy reorganization, major business cooperation, or the introduction of strategic investors.
(3) Media Reports, Market Rumors, and Hot Concepts: Following self-inspection, the company found no media reports or market rumors in recent times, other than those already disclosed, that would have a significant impact on the stock trading price, and there are no other hot concept matters involved.
(4) Upon verification, the companys directors, senior management, and largest shareholder have not engaged in buying or selling the companys stock during the period of abnormal stock trading fluctuations.
The companys board of directors confirms that as of the date of this announcement, there are no matters that should have been disclosed according to the "Shanghai Stock Exchange Listing Rules" and other relevant regulations that have not been disclosed, nor any related planning, discussions, intentions, agreements, etc. The board has also not learned of any undisclosed information that should have been disclosed and could substantially affect the companys stock trading price; there are no corrections or supplements needed to the information previously disclosed by the company.
Related Articles

XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.

HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.

HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.
XIAOMI-W (01810) invested HKD 49.9504 million on August 6th to repurchase 1.862 million shares.

HAOHAI BIOTEC (06826) subsidiary has obtained a medical device registration certificate for its trifocal toric intraocular lens product.

HENG TAI (00197): Chan Wai Ying has been appointed as an independent non-executive director.

RECOMMEND





